Investigational Drug Development
With our sights set on helping patients along the entire care pathway, Fujifilm has made the significant investment required in research and clinical development for being successful in the pharmaceutical industry.
From photography to pharmaceuticals
With the goal of enhancing patient care and quality of life, the development of therapies is crucial to deliver promising solutions for unmet medical needs.
Fujifilm is creating a wide variety of drug candidates for areas such as cancer, infectious diseases and central nervous system diseases, by applying proprietary technologies harnessed through Fujifilm’s long-standing operations in photographic films.
To advance its role in treatment, Fujifilm is currently conducting oncology clinical trials in the U.S.
The drug candidates created or tested by direct or indirect affiliates of FUJIFILM Holdings Corporation that are referred to on this website and on FUJIFILM Pharmaceuticals U.S.A. website are still at development stage and not yet approved for commercialization. A future use and commercialization will be subject to the prior granting of a marketing authorization in the given territory and compliance with applicable laws.